免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

RadGil2

K号: K201177 · 2020-08-17

决定日期2020-08-17
产品代码MOT
决定实质等同

器械摘要

RadGil2 is the device name listed in this FDA 510(k) record. The listed applicant is R3 X-Ray L.L.C. It received FDA 510(k) clearance on 2020-08-17 under 510(k) number K201177. The device is classified under product code MOT. FDA Decision: Substantially Equivalent.

常见问题

What is the RadGil2?

RadGil2 is a medical device that received FDA 510(k) clearance on 2020-08-17. The listed applicant is R3 X-Ray L.L.C. The 510(k) number is K201177.

When did RadGil2 receive FDA 510(k) clearance?

RadGil2 received FDA 510(k) clearance on 2020-08-17, under 510(k) number K201177.

Who is the listed applicant for RadGil2?

The FDA 510(k) record lists R3 X-Ray L.L.C as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RadGil2?

The FDA product code for RadGil2 is MOT.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:MOT)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑